Report Published: Kinase Inhibitors Market

Research Report
Kinase Inhibitors
Market
Synopsis
The report provides market analysis, information and insights into “Kinase Inhibitors
Market ”
Market Analysis
Protein kinase is an enzyme that shuffles protein structure by transferring phosphate
collected from ATP(Adenosine Triphosphate) . Protein kinase help in regulating variety
of cell functions such as cell cycle, cell differentiation, cell proliferation and apoptosis.
These cell processes are used in regulating various cell activities in cancer. The global
inhibitors market was valued at approximately $105 billion. Increase in incident of
cancer diseases is driving the growth for kinase inhibitor market. According to American
Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. This
shows potential for kinase inhibitors in cancer therapies. The growth of kinase inhibitor
market is hindered by cost of treatment and lack of funds in conducting research. For
Example, the cost of TKI (Tyrosin kinase inhibitors) was approximately $26,400 in nonpharmaceutical spending in 2012
View more details @ : http://www.bigmarketresearch.com/kinase-inhibitors-market
Key Players Of Market
Increase in clinical trials for commercialization of kinase inhibitors in cancer treatment is
facing challenges due to strict government regulations. However, an increase in
investment from pharmaceutical companies is promoting the growth for kinase
inhibitor market. This report provides an in depth analysis of clinical development and
reimbursement strategies adopted by respective governments.
Key companies include in the report are Bristol-Myers Squibb, Boehringer Ingelheim,
Cytrx Corporation, Eisai Inc. Eton Bioscience Inc., Glaxosmithkline, Merck Serono Sa,
Novartis International Ag, Osi Pharmaceuticals Llc, Pfizer
KEY BENEFITS
• The report provides key developmental strategies adopted by top market players
engaged in this business so that companies involved in development kinase inhibitors
market can get competitive intelligence of their competitors
• The report focuses on market estimation for types of kinase inhibitors and geographic
segments are derived from current market scenario and expected market trends that
are forecasted
• Competitive landscape and competitor strategy analysis would help in better planning
and execution of business strategies
• SWOT analysis and strategic developments included in the report for key market
players are included in the report to get better understanding of potential opportunities
and challenges for companies
• Impact analysis of top 10 factors to provide market situation to top management of
surgical equipment market
KEY MARKET SEGMENTS
• Tyrosin kinase inhibitors (TKI)
• Receptor Tyrosine Kinase Inhibitors
EGFR
PDGFR
VEGFR
HER2
• Non-Receptor Tyrosine Kinase Inhibitors
BCR-ABL
Janus Kinase (JAK) Inhibitor
Mesenchymal Epithelial Transition Growth Factor (c-MET)
Spleen Tyrosine Kinase (SYK) Inhibitors
• Mulikinase inhibitors
• Threonine kinase inhibitor
• mTOR Kinase Inhibitors
• B RAF
• RHO Kinase Inhibitors
KEY MARKET SEGMENTS
• Cyclin Dependant Kinase Inhibitor
• Aurora Kinase Inhibitors
• MAP/MEK Kinase Inhibitors
BY GEOGRAPHY
• North America
• Europe
• Asia-Pacific
• RoW
KEY AUDIENCES
• Pharmaceutical companies
• Private and Government research institutes
• Academic Institutes
• Healthcare facilities
Summary
The report provides key developmental strategies adopted by top market players
engaged in this business so that companies involved in development kinase inhibitors
market can get competitive intelligence of their competitors
Enquire About Report @ Enquiry: http://www.bigmarketresearch.com/reportenquiry/22732
Contact Us
Big Market Research
Deep Joshi
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Direct : + 1-503-894-6022
Toll Free : + 1-800-910-6452
Fax : +1 (855) 550-5975
Email: [email protected]
Web: http://www.bigmarketresearch.com

Protein kinase is an enzyme that shuffles protein structure by transferring phosphate collected from ATP(Adenosine Triphosphate) . Protein kinase help in regulating variety of cell functions such as cell cycle, cell differentiation, cell proliferation and apoptosis. These cell processes are used in regulating various cell activities in cancer. The global inhibitors market was valued at approximately $105 billion. Increase in incident of cancer diseases is driving the growth for kinase inhibitor market. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. This shows potential for kinase inhibitors in cancer therapies. The growth of kinase inhibitor market is hindered by cost of treatment and lack of funds in conducting research. For Example, the cost of TKI (Tyrosin kinase inhibitors) was approximately $26,400 in non-pharmaceutical spending in 2012